Koo Jeong Kang
Koo Jeong Kang publishes mostly in Surgery, Hepatology and Molecular Biology, on topics such as Cholangiocarcinoma and Gallbladder Cancer Studies, Hepatocellular Carcinoma Treatment and Prognosis and Cancer Genomics and Diagnostics.
- World rank
- #79,168 of 7,710,434 ranked researchers
- Rank in South Korea
- #348 of 162,609
- Works
- 246
- Citations
- 57k
- Citations per work
- 233.3
What does Koo Jeong Kang research?
Koo Jeong Kang's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (22%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences13153.2%
- Medicine13153.2%
- Everything else6225.1%
- Life Sciences5321.7%
- 1Surgery21% of their works
- 2Hepatology14% of their works
- 3Molecular Biology11% of their works
- 4Cancer Research10% of their works
- 5Oncology10% of their works
- 6Pulmonary and Respiratory Medicine9% of their works
Research topics
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Genomics and Diagnostics
- Organ Transplantation Techniques and Outcomes
- Pancreatic and Hepatic Oncology Research
- Gallbladder and Bile Duct Disorders
- Liver Disease and Transplantation
- Liver Disease Diagnosis and Treatment
Which keywords describe Koo Jeong Kang's research?
The keywords of their largest research topics: Cholangiocarcinoma, Hepatocellular Carcinoma, Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma, Liver Cancer, Management, Cancer Genomics and Mutational Signatures.
- NASH
- Liver Cirrhosis
- ERCP
- Surgical Complications
- Liver Transplantation
- Mutational Signatures
- Management
- Intrahepatic Cholangiocarcinoma
- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Biliary Tract Cancer
- Liver Cancer
- Cancer Genomics
- Ischemia-Reperfusion Injury
- Pancreatic Cancer
- Cholecystitis
- Hepatic Encephalopathy
- NAFLD
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Cholangiocarcinoma872 topics
- Hepatocellular Carcinoma692 topics
- Biliary Tract Cancer621 topic
- Intrahepatic Cholangiocarcinoma621 topic
- Liver Cancer511 topic
- Management511 topic
- Cancer Genomics421 topic
- Mutational Signatures421 topic
- Ischemia-Reperfusion Injury361 topic
- Liver Transplantation361 topic
- Pancreatic Cancer301 topic
- Surgical Complications301 topic
- Cholecystitis251 topic
- ERCP251 topic
- Hepatic Encephalopathy231 topic
- Liver Cirrhosis231 topic
- NAFLD181 topic
- NASH181 topic
Where does Koo Jeong Kang work?
Koo Jeong Kang's main affiliation in the publication record is Keimyung University, South Korea.
How many publications and citations does Koo Jeong Kang have?
OpenAlex counts 246 works and 57,386 citations for Koo Jeong Kang, an h-index of 68, ranking #79,168 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Koo Jeong Kang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.